Cargando…
A novel Chimpanzee serotype-based adenoviral vector as delivery tool for cancer vaccines
The use of adenovirus (Ad) as vaccine vectors is hindered by pre-existing immunity to human Ads in most of the human population. In order to overcome this limitation, uncommon alternative Ad serotypes need to be utilized. In this study, an E1–E3 deleted recombinant Ad based on the chimpanzee serotyp...
Autores principales: | Peruzzi, Daniela, Dharmapuri, Sridhar, Cirillo, Agostino, Bruni, Bruno Ercole, Nicosia, Alfredo, Cortese, Riccardo, Colloca, Stefano, Ciliberto, Gennaro, La Monica, Nicola, Aurisicchio, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115565/ https://www.ncbi.nlm.nih.gov/pubmed/19162112 http://dx.doi.org/10.1016/j.vaccine.2008.12.051 |
Ejemplares similares
-
Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer, Katie, et al.
Publicado: (2017) -
Emerging Cancer Vaccines: The Promise of Genetic Vectors
por: Aurisicchio, Luigi, et al.
Publicado: (2011) -
Rescue of chimeric adenoviral vectors to expand the serotype repertoire
por: Roy, Soumitra, et al.
Publicado: (2007) -
A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection
por: Hartnell, Felicity, et al.
Publicado: (2019) -
A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C
por: Napolitano, Federico, et al.
Publicado: (2020)